These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 28222786)

  • 1. Post translational modification of Parkin.
    Chakraborty J; Basso V; Ziviani E
    Biol Direct; 2017 Feb; 12(1):6. PubMed ID: 28222786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel Zn2+-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin.
    Hristova VA; Beasley SA; Rylett RJ; Shaw GS
    J Biol Chem; 2009 May; 284(22):14978-86. PubMed ID: 19339245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-translational modification of Parkin and its research progress in cancer.
    Ding D; Ao X; Liu Y; Wang YY; Fa HG; Wang MY; He YQ; Wang JX
    Cancer Commun (Lond); 2019 Nov; 39(1):77. PubMed ID: 31753025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The three 'P's of mitophagy: PARKIN, PINK1, and post-translational modifications.
    Durcan TM; Fon EA
    Genes Dev; 2015 May; 29(10):989-99. PubMed ID: 25995186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.
    Hampe C; Ardila-Osorio H; Fournier M; Brice A; Corti O
    Hum Mol Genet; 2006 Jul; 15(13):2059-75. PubMed ID: 16714300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin phosphorylated at Ser57 hyper-activates parkin.
    George S; Wang SM; Bi Y; Treidlinger M; Barber KR; Shaw GS; O'Donoghue P
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt B):3038-3046. PubMed ID: 28689991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospho-ubiquitin: upending the PINK-Parkin-ubiquitin cascade.
    Matsuda N
    J Biochem; 2016 Apr; 159(4):379-85. PubMed ID: 26839319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkin and mitochondrial quality control: toward assembling the puzzle.
    Winklhofer KF
    Trends Cell Biol; 2014 Jun; 24(6):332-41. PubMed ID: 24485851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SH3 domains from a subset of BAR proteins define a Ubl-binding domain and implicate parkin in synaptic ubiquitination.
    Trempe JF; Chen CX; Grenier K; Camacho EM; Kozlov G; McPherson PS; Gehring K; Fon EA
    Mol Cell; 2009 Dec; 36(6):1034-47. PubMed ID: 20064468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity.
    Im E; Chung KC
    J Neurochem; 2015 Aug; 134(4):756-68. PubMed ID: 25963095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation mechanisms of the E3 ubiquitin ligase parkin.
    Panicker N; Dawson VL; Dawson TM
    Biochem J; 2017 Aug; 474(18):3075-3086. PubMed ID: 28860335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of parkin reveals mechanisms for ubiquitin ligase activation.
    Trempe JF; Sauvé V; Grenier K; Seirafi M; Tang MY; Ménade M; Al-Abdul-Wahid S; Krett J; Wong K; Kozlov G; Nagar B; Fon EA; Gehring K
    Science; 2013 Jun; 340(6139):1451-5. PubMed ID: 23661642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation by PINK1 releases the UBL domain and initializes the conformational opening of the E3 ubiquitin ligase Parkin.
    Caulfield TR; Fiesel FC; Moussaud-Lamodière EL; Dourado DF; Flores SC; Springer W
    PLoS Comput Biol; 2014 Nov; 10(11):e1003935. PubMed ID: 25375667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkin structure and function.
    Seirafi M; Kozlov G; Gehring K
    FEBS J; 2015 Jun; 282(11):2076-88. PubMed ID: 25712550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Ubl/ubiquitin switch in the activation of Parkin.
    Sauvé V; Lilov A; Seirafi M; Vranas M; Rasool S; Kozlov G; Sprules T; Wang J; Trempe JF; Gehring K
    EMBO J; 2015 Oct; 34(20):2492-505. PubMed ID: 26254305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson's disease.
    Beasley SA; Hristova VA; Shaw GS
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3095-100. PubMed ID: 17360614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insights into Parkin substrate lysine targeting from minimal Miro substrates.
    Klosowiak JL; Park S; Smith KP; French ME; Focia PJ; Freymann DM; Rice SE
    Sci Rep; 2016 Sep; 6():33019. PubMed ID: 27605430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity.
    Yao D; Gu Z; Nakamura T; Shi ZQ; Ma Y; Gaston B; Palmer LA; Rockenstein EM; Zhang Z; Masliah E; Uehara T; Lipton SA
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10810-4. PubMed ID: 15252205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-functional E3 ligases Parkin and C-terminus Hsp70-interacting protein in neurodegenerative disorders.
    Kumar P; Pradhan K; Karunya R; Ambasta RK; Querfurth HW
    J Neurochem; 2012 Feb; 120(3):350-70. PubMed ID: 22098618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the E3 ubiquitin ligase Parkin.
    Caulfield TR; Fiesel FC; Springer W
    Biochem Soc Trans; 2015 Apr; 43(2):269-74. PubMed ID: 25849928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.